These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10479124)

  • 1. Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.
    Sakuma I; Enomoto N; Kurosaki M; Izumi N; Marumo F; Sato C
    J Infect Dis; 1999 Oct; 180(4):1001-9. PubMed ID: 10479124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
    Pawlotsky JM; Germanidis G; Neumann AU; Pellerin M; Frainais PO; Dhumeaux D
    J Virol; 1998 Apr; 72(4):2795-805. PubMed ID: 9525599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
    Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
    J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K; Ito H; Watanabe K; Yano M; Ishigami M; Mizutani T; Sasaki Y; Goto H
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha.
    Gerotto M; Dal Pero F; Sullivan DG; Chemello L; Cavalletto L; Polyak SJ; Pontisso P; Gretch DR; Alberti A
    J Viral Hepat; 1999 Sep; 6(5):367-72. PubMed ID: 10607252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
    Brillet R; Penin F; Hezode C; Chouteau P; Dhumeaux D; Pawlotsky JM
    J Infect Dis; 2007 Feb; 195(3):432-41. PubMed ID: 17205483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
    N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L; Cresta P; Perrin M; Lunel F; Opolon P; Agut H; Huraux JM
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.
    Sarrazin C; Bruckner M; Herrmann E; Rüster B; Bruch K; Roth WK; Zeuzem S
    Virology; 2001 Oct; 289(1):150-63. PubMed ID: 11601926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of HCV NS5A quasispecies during IFN therapy in patients with chronic HCV.
    Paterson M; Laxton C; Goldin RD; Ackrill AM; Foster GR
    Dig Dis Sci; 2001 Jul; 46(7):1399-408. PubMed ID: 11478490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.
    Puig-Basagoiti F; Forns X; Furčić I; Ampurdanés S; Giménez-Barcons M; Franco S; Sánchez-Tapias JM; Saiz JC
    J Gen Virol; 2005 Apr; 86(Pt 4):1067-1075. PubMed ID: 15784900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.
    Pascu M; Martus P; Höhne M; Wiedenmann B; Hopf U; Schreier E; Berg T
    Gut; 2004 Sep; 53(9):1345-51. PubMed ID: 15306598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infection.
    Yoshioka K; Kobayashi M; Orito E; Watanabe K; Yano M; Sameshima Y; Kusakabe A; Hirofuji H; Fuji A; Kuriki J; Arao M; Murase K; Mizokami M; Kakumu S
    J Viral Hepat; 2001 Nov; 8(6):421-9. PubMed ID: 11703573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.
    Polyak SJ; McArdle S; Liu SL; Sullivan DG; Chung M; Hofgärtner WT; Carithers RL; McMahon BJ; Mullins JI; Corey L; Gretch DR
    J Virol; 1998 May; 72(5):4288-96. PubMed ID: 9557719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.
    Sáiz JC; López-Labrador FX; Ampurdanés S; Dopazo J; Forns X; Sánchez-Tapias JM; Rodés J
    J Infect Dis; 1998 Apr; 177(4):839-47. PubMed ID: 9534954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between NS5A gene sequence and response to interferon therapy in chronic hepatitis C patients in Shanghai].
    Hu Y; Tang M; Jiang W; Wu Y; Yuan Z; Wen Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):114-8. PubMed ID: 12196819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural analysis of the PKR-binding region of HCV 1b samples from patients with chronic hepatitis C and the correlation with IFN-sensitivity].
    Gervain J; Czibula A; Simon J; Kalmár T
    Orv Hetil; 2003 Jun; 144(24):1179-84. PubMed ID: 12866147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.